Standardization of broth microdilution method for Mycobacterium tuberculosis

Area of Science:

• Microbiology
• Infectious Diseases
• Clinical Diagnostics

Background:

• Tuberculosis drug susceptibility testing is crucial for effective treatment.
• Conventional methods can be time-consuming and complex.
• There is a need for accurate, rapid, and accessible diagnostic tools.

Purpose of the Study:

• To evaluate the accuracy and feasibility of a broth microdilution method (BMM) for determining minimal inhibitory concentrations (MICs) of anti-tuberculosis drugs.
• To compare BMM performance against the gold standard proportional method.
• To assess the time efficiency and practical advantages of BMM.

Main Methods:

• Broth microdilution method (BMM) was employed to test drug susceptibility.
• Fifty clinical isolates of Mycobacterium tuberculosis and the H37Rv strain were evaluated.
• Drugs tested included isoniazid (H), rifampicin (R), ethambutol (E), streptomycin (S), and pyrazinamide (Z).
• Results were compared with the gold standard proportional method on Lowenstein-Jensen medium.

Main Results:

• BMM demonstrated high sensitivity (100%) for all tested drugs.
• Specificities ranged from 85% (pyrazinamide) to 100% (rifampicin).
• BMM provided faster results (14-20 days) compared to the proportional method (20-28 days).
• The method is user-friendly, requires no special equipment, and avoids radioactive materials.

Conclusions:

• The broth microdilution method is an accurate and feasible approach for Mycobacterium tuberculosis drug susceptibility testing.
• BMM offers a faster, simpler, and potentially more accessible alternative to conventional methods.
• This method facilitates the testing of multiple drugs and concentrations, aiding in personalized treatment strategies.